Literature DB >> 15306536

The role of virus-specific immunoglobulin E in airway hyperresponsiveness.

Azzeddine Dakhama1, Jung-Won Park, Christian Taube, Kosuke Chayama, Annette Balhorn, Anthony Joetham, Xu-Dong Wei, Rhi-Hua Fan, Christina Swasey, Nobuaki Miyahara, Taku Kodama, Alberto Alvarez, Katsuyuki Takeda, Erwin W Gelfand.   

Abstract

Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis during infancy and is associated with subsequent wheezing and asthma, but the nature of this association is not fully understood. We investigated the role of RSV-specific IgE antibodies in the pathophysiology of virus-induced airway dysfunction in a mouse model. Lung infection with RSV resulted in significant increases in mRNA expression for IgE and both of its high- and low-affinity receptors. In serum, virus-specific IgE antibodies reached peak levels by Day 21 after infection. Data from in vitro experiments show that RSV can induce mast cell degranulation, but only if these cells are sensitized with specific IgE. When passively sensitized in vivo with virus-specific IgE, mice developed exaggerated airway responsiveness to methacholine on airway infection, an effect that required the high-affinity receptor of IgE. These data suggest that RSV-specific IgE may contribute to the pathophysiology of airway dysfunction in children who develop this class of specific antibody.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306536     DOI: 10.1164/rccm.200311-1610OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

Review 1.  The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors:  Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

2.  Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells.

Authors:  J Lappalainen; J Rintahaka; P T Kovanen; S Matikainen; K K Eklund
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

Review 3.  Pediatric asthma: a different disease.

Authors:  Erwin W Gelfand
Journal:  Proc Am Thorac Soc       Date:  2009-05-01

Review 4.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

5.  IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus.

Authors:  Young-Mok Lee; Nobuaki Miyahara; Katsuyuki Takeda; John Prpich; Anita Oh; Annette Balhorn; Anthony Joetham; Erwin W Gelfand; Azzeddine Dakhama
Journal:  Am J Respir Crit Care Med       Date:  2007-10-25       Impact factor: 21.405

Review 6.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

7.  The prevalence and identity of Chlamydia-specific IgE in children with asthma and other chronic respiratory symptoms.

Authors:  Katir K Patel; Erica Anderson; Paul S Salva; Wilmore C Webley
Journal:  Respir Res       Date:  2012-04-18

8.  Inhibition of CD23-mediated IgE transcytosis suppresses the initiation and development of allergic airway inflammation.

Authors:  S Palaniyandi; X Liu; S Periasamy; A Ma; J Tang; M Jenkins; W Tuo; W Song; A D Keegan; D H Conrad; X Zhu
Journal:  Mucosal Immunol       Date:  2015-03-18       Impact factor: 7.313

9.  Need for a safe vaccine against respiratory syncytial virus infection.

Authors:  Joo-Young Kim; Jun Chang
Journal:  Korean J Pediatr       Date:  2012-09-14

10.  Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia.

Authors:  Mitchell H Grayson; Dorothy Cheung; Michelle M Rohlfing; Robert Kitchens; Daniel E Spiegel; Jennifer Tucker; John T Battaile; Yael Alevy; Le Yan; Eugene Agapov; Edy Y Kim; Michael J Holtzman
Journal:  J Exp Med       Date:  2007-10-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.